<bill session="115" type="hc" number="146" updated="2023-01-11T13:40:53Z">
  <state datetime="2018-12-20">REFERRED</state>
  <status>
    <introduced datetime="2018-12-20"/>
  </status>
  <introduced datetime="2018-12-20"/>
  <titles>
    <title type="display">Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.</title>
    <title type="official" as="introduced">Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-12-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-12-20" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-12-20">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Marketing and advertising"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-01-30T20:22:32Z" status="Introduced in House">Expresses the sense of Congress that:

 the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; the Centers for Medicare &amp; Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; and the proposed rule by the CMS published in the Federal Register on October 18, 2018, when finalized, shall be codified without change.</summary>
</bill>
